Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs BBC overlap: 16% of top holdings shared

Bottom line

How much do XBI and BBC overlap?

16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 6.5% of XBI's assets and 4.5% of BBC's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIBBC
Weight overlap (top 25)16%
Shared holdings5
Weight in shared holdings6.5%4.5%
Total positions161132
Expense ratio0.35%0.65%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XBI and BBC have in common

Holding% of XBI% of BBCOverlap
Apogee Therapeutics Inc1.49%1.02%1.02%
Oruka Therapeutics Inc1.38%0.93%0.93%
Erasca Inc1.27%0.87%0.87%
SELLAS Life Sciences Group Inc1.19%0.86%0.86%
Dianthus Therapeutics Inc1.18%0.87%0.87%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Moderna Inc — 1.41%
  3. Twist Bioscience Corp — 1.41%
  4. Kymera Therapeutics Inc — 1.36%
  5. Viking Therapeutics Inc — 1.30%
  6. Praxis Precision Medicines Inc — 1.29%
  7. Revolution Medicines Inc — 1.20%
  8. Rhythm Pharmaceuticals Inc — 1.20%
  9. CG oncology Inc — 1.20%
  10. Vaxcyte Inc — 1.19%
  11. Cytokinetics Inc — 1.18%
  12. Natera Inc — 1.16%
  13. Scholar Rock Holding Corp — 1.16%
  14. Roivant Sciences Ltd — 1.16%
  15. Mirum Pharmaceuticals Inc — 1.16%

Only in BBC

  1. Dreyfus Government Cash Manage — 3.48%
  2. First Tracks Biotherapeutics Inc — 1.67%
  3. Mbx Biosciences Inc — 1.24%
  4. Ataibeckley Inc — 1.23%
  5. Monopar Therapeutics Inc — 1.21%
  6. Definium Therapeutics Inc — 1.18%
  7. Xencor Inc — 1.10%
  8. Zenas Biopharma Inc — 1.06%
  9. Uniqure Nv — 1.06%
  10. Vor Biopharma Inc — 0.99%
  11. Regenxbio Inc — 0.97%
  12. Lb Pharmaceuticals Inc — 0.94%
  13. Damora Therapeutics Inc — 0.93%
  14. Amylyx Pharmaceuticals Inc — 0.93%
  15. Dyne Therapeutics Inc — 0.93%

Asset mix

Asset typeXBIBBC
Stocks99.9%99.8%
Cash & short-term funds5.9%3.5%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXBIBBC
US100.8%86.7%
KY—5.3%
CA0.2%3.4%
NL1.0%3.0%
IE1.2%1.6%
GB—1.3%
BM1.2%—
CH1.0%0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XBI and BBC overlap?
About 16% by weight. 5 securities appear in both funds' top 25 holdings; they make up 6.5% of XBI's assets and 4.5% of BBC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and BBC have in common?
The largest shared holdings are Apogee Therapeutics Inc, Oruka Therapeutics Inc, Dianthus Therapeutics Inc, Erasca Inc, SELLAS Life Sciences Group Inc.
Should I own both XBI and BBC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or BBC?
XBI is broader, with 161 positions versus 132 for BBC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.